About
Roopal Thakkar, M.D., is AbbVie's Executive Vice President, Research & Development and Chief Scientific Officer. He previously served as Senior Vice President of Development and Regulatory Affairs and Chief Medical Officer, and earlier as Vice President, Global Regulatory Affairs and R&D Quality Assurance. Dr. Thakkar joined Abbott in 2003 and was first appointed as an AbbVie corporate officer in December 2023.
Roles
AbbVie Inc.
Executive Vice President, Research & Development and Chief Scientific Officer · Current role
Dec 2023–present
AbbVie
Senior Vice President, Development and Regulatory Affairs and Chief Medical Officer
2022 - 2023
AbbVie
Vice President, Global Regulatory Affairs and R&D Quality Assurance
2019 - 2022
AbbVie
Vice President, Global Regulatory Affairs · Joined Abbott in 2003
2015 - 2019
Fixed Compensation
FY 2025Base Salary
$1,146,154
Change in Pension Value & Nonqualified Deferred Compensation Earnings
$1,416,715
All Other Compensation
$59,767
Performance Compensation
Data from FY 2025Cash incentive
Annual Cash Incentive (Non-Equity Incentive Plan Compensation)
$2,350,000
Target Opportunity
—
ProgramAbbVie annual cash incentive plan
Stock awards
Stock Awards (grant-date fair value)
$3,980,457
VehiclesPerformance shares (EPS + relative TSR, 0-250% of target) and performance-vested RSUs (relative ROIC, 0-200% of target)
2025 resultAdjusted diluted EPS performance banked the 2025 performance-share award at 200% of target (TSR-modified vesting through Dec 31, 2027); relative ROIC vested one-third of the PVRSU award at 200% of target
Option Awards (grant-date fair value)
$959,750
VestingOne-third after each of years one, two and three of service
Also at AbbVie Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.